Complication of endovascular Х-ray examination in patients with coronary heart disease with diabetes mellitus and their ways of correction


Cite item

Full Text

Abstract

Complication of endovascular Х-ray examination in patients with coronary heart disease in diabetes mellitus is associated with the risk of nephropathy induced by the introduction of contrast agents (CIN). The frequency of development of CIN in patients with coronary heart disease and diabetes mellitus type 2 after coronary angiography. KIN more likely to develop in patients with type 2 diabetes compared with patients without glucose metabolism. Discussed prevention measures that reduce the risk of developing CIN.

About the authors

Воронежская государственная медицинская академия им. Н.Н.Бурденко

Author for correspondence.
Email: ustruk@mail.ru
доктор медицинских наук, профессор, заведующий кафедрой анестезиологии и реаниматологии ИПМО Воронежской государственной медицинской академии им. Н.Н.Бурденко

Воронежская областная клиническая больница № 1

Email: lvkozlova@mail.ru
врач отделения эндокринологии Воронежской областной клинической больницы №1

Воронежская государственная медицинская академия им. Н.Н.Бурденко

Email: ustruk@mail.ru
ассистент кафедры анестезиологии и реаниматологии ИПМО Воронежской государственной медицинской академии им. Н.Н.Бурденко

References

  1. Karmazanovskii G.G., Poliaev Iu.A., Iudin A.L., Shimanovskii N.L. Sovremennye rentgenokontrastnye veshchestva i nefropatiia: kak snizit' risk razvitiia pochechnoi nedostatochnosti? Meditsinskaia vizualizatsiia 2007; 1:135-144.
  2. Bagshaw S.M., Ghali W.A. Acetylcyste-ine for prevention of contrast-induced ne-phropathy after intravascular angiography: a systematic review and meta-analysis. BMC Med. 2004;2:38.
  3. Bagshaw S.M., Ghali W.A. Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Arch. Intern. Med. 2005;165(10):1087-93.
  4. Erley C.M., Duda S.H., Rehfuss D. et al. Prevention of radiocontrast-media-induced nephropathy in patients with pre existing renal insuffi ciency by hydration in combination with the adenosine antagonist theophylline. Nephrol. Dial. Transplant. 1999;14(5):1146-9.
  5. Heinrich M.C., Kuhlmann M.K., Grgic A. et al. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso- osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology 2005;235:843.
  6. Heyman S.N., Reichman J., Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest. Radio 1999; 34:68-91.
  7. Katholi R.E., Woods W.T. Jr., Taylor G.L. et al. Oxygen free radicals and contrast nephropathy. Am. J. Kidney Dis. 1998;32:64-71.
  8. Kshirsagar A.V., Poole C., Mottl A. et al. N-acetylcysteine for the prevention of ra-diocontrast induced nephropathy: a meta- analysis of prospective controlled trials. J. Am. Soc. Nephrol. 2004;15:761-9.
  9. Liss P. et al. Renal failure in 57925 patients undergoing coro nary procedures using iso-osmolar or low osmolar contrast media. Kidney Int. 2006; 70(10):1811-1817.
  10. Marenzi G., Assanelli E., M.D., Marana I., et al.N-Acetylcysteine and
  11. Con trast-Induced nephropathy in primary angioplasty. N. Engl. J. Med. 2006;354:2773-82.
  12. Pannu N., Manns B., Lee H., Tonelli M. Systematic review of the impact of N-ace-tylcysteine on contrast nephropathy. Kidney Int., 2004; 65:1366-74.
  13. Persson P.B., Hansell P., Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005; 68:14.
  14. Spargias K., Alexopoulos E., Kyrzopoulos S. et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or interven tion. Circulation, 2004;110(18):2837-42
  15. Marenzi G., Lauri G., Campodonico J, et al. Comparison of two hemofi ltration protocols for prevention of contrastinduced nephropathy in high-risk patients. Am. J. Med. 2006; 119:155.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2010 ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies